ID: ALA5268768

Max Phase: Preclinical

Molecular Formula: C17H19N3OS

Molecular Weight: 313.43

Associated Items:

Representations

Canonical SMILES:  CCCC(=O)Nc1nc2ccccc2c2sc(CCC)nc12

Standard InChI:  InChI=1S/C17H19N3OS/c1-3-7-13(21)19-17-15-16(22-14(20-15)8-4-2)11-9-5-6-10-12(11)18-17/h5-6,9-10H,3-4,7-8H2,1-2H3,(H,18,19,21)

Standard InChI Key:  NCMHCQNNPCJRNF-UHFFFAOYSA-N

Associated Targets(Human)

Toll-like receptor 8 1853 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 313.43Molecular Weight (Monoisotopic): 313.1249AlogP: 4.54#Rotatable Bonds: 5
Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.41CX Basic pKa: CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.75Np Likeness Score: -1.21

References

1. Kaushik D, Kaur A, Petrovsky N, Salunke DB..  (2021)  Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.,  12  (7.0): [PMID:34355178] [10.1039/D1MD00031D]

Source